Alexion Pharmaceuticals, Inc.
(NASDAQ : ALXN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
TSROTESARO, Inc.
0.12%73.7514.4%$592.04m
AMGNAmgen Inc.
-0.13%189.841.2%$550.59m
GILDGilead Sciences, Inc.
0.91%65.710.9%$540.30m
CELGCelgene Corporation
0.08%68.191.2%$494.38m
BIIBBiogen Inc.
-2.96%303.821.3%$345.17m
ILMNIllumina, Inc.
1.63%315.963.5%$345.07m
REGNRegeneron Pharmaceuticals, Inc.
0.13%375.992.6%$269.43m
AAgilent Technologies, Inc.
1.12%68.611.5%$216.95m
VRTXVertex Pharmaceuticals Incorporated
1.23%168.211.9%$216.00m
ALXNAlexion Pharmaceuticals, Inc.
-0.03%109.502.0%$153.78m
INCYIncyte Corporation
1.03%65.492.5%$98.18m
EXASExact Sciences Corporation
0.31%67.3225.3%$94.00m
BLUEBluebird Bio, Inc.
-2.33%102.1414.4%$85.49m
SRPTSarepta Therapeutics, Inc.
0.02%115.7215.4%$84.47m
GBTGlobal Blood Therapeutics Inc
0.12%41.627.0%$80.94m

Company Profile

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.